CPHI Milan 2024
Connect with our API experts and explore industry-leading solutions.
Meet us at booth 24A41
October 08 - 10, 2024
Fiera Milano, ItalyOur Team at CPHI Milan 2024
Deepak Sapra
CEO, Pharmaceutical Services & Active Ingredients
Gunjan Singh
Vice President and Head, API - Mature Markets
Azhar Khan
Vice President and Head, API - Emerging Markets
Dr. NM Sekhar
Dr. NM Sekhar, Vice President, API R&D
B Vivek
Executive VP & Global Head - Supply, Demand Planning & Delivery
Dr. A Kalyan Chakravarthy
Executive VP & Global Head - Supply, Demand Planning & Delivery
Gustavo Mayrink De Castro Marques
Vice President and Head, API Sales & Marketing, LATAM
Kalpesh Modi
Vice President, and Head – EU/CIS Market, API & B2B Collaborations
Karun Gaur
Vice President and Head, Strategic Projects API
R Lalitha Kumari
Global Head of API Product Management & Head of Sales - US & Canada
Nirav Shah
Vice President, and Head, API - North Asia
Rohan Kaushik
Associate Vice President, API - BD & Portfolio
Siddhartha Deshpande
Associate Vice President, API Sales & Marketing, SEAMEA
Pratik Singh Bais
Director, API - Sales & BD, Mexico & Canada
Rohit Jayant Dash
Rohit Jayant Dash, Director - API Sales & Marketing, GCC, Africa & Turkey
Ashish Rana
Ashish Rana, Director, API - BD & Sales, Europe
Yuri Alberto Pereira
Director, API Sales & Marketing – LATAM
About Dr.Reddy’s API Business
We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 150+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.
Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.
-
250+ APIs
-
8 Manufacturing sites
-
More than 1873 drug master files across global markets.
-
Over 325 ANDAs
-
More than 1000 patents field, and more than 70 own patents granted
-
Experience with complex APIs and formulations supporting early market entries.
-
Preferred pharma API supplier for pharma companies in more than 80 countries.
Sustainability is deeply embedded in our purpose and forms the core of our organization.
Our journey began with APIs in 1984, and we evolved from small molecules to large molecules and from APIs to finished formulations over the decades. Amidst this evolution, what has remained constant at the heart of our organization is a deep commitment to patients and the customers we serve through our core principles of collaboration and sustainability.
By the end of FY2024, we had served over 700 million patients and continue our endeavours to reach over 1.5 billion patients globally by 2030. This means almost one in every five people on this planet will use Dr. Reddy’s product or service. The health of people is strongly linked to the health of our planet. That's why our integrated report also shows how sustainability and business are strongly linked.
What we achieved in the past year:
Our Plants
About CPHI Milan 2024
CPHI Milan is a global pharmaceutical event uniting the pharmaceutical community to advance human health. With a history spanning 35 years, the event has become a cornerstone for fostering connections and inspiring partnerships across the industry. CPHI Milan is a platform for professionals to engage with the latest innovations, share knowledge, and collaborate on projects that shape the future of pharmaceuticals.
Key Highlights of CPHI Milan 2024:
-
Global Participation: The event expects to welcome 62,000 attendees and 2,400 exhibitors from 168+ countries, demonstrating its significant international reach.
-
Diverse Exhibition: Attendees can explore a wide range of products and services across various pharmaceutical sectors.
-
Networking Opportunities: CPHI Milan offers numerous opportunities for attendees to connect, build relationships, and forge partnerships.
-
Knowledge Exchange: The event features conferences, seminars, and workshops where industry experts share insights and discuss the latest trends.
-
Celebration of 35 Years: CPHI Milan 2024 marks a special milestone, celebrating 35 years of uniting the pharma community.
Our Achievement (awards)
25/04/2024
USP recognized Dr. Reddy’s with a crystal award for significant contribution towards “New and modernized monograph submissions”
05/04/2024
Dr. Reddys Strategic collaboration with Industrial Promotion Services (IPS) to support the East African Combined Pharmaceutical Center (EACPC) in Kenya
05/12/2023
Dr. Reddy's Pioneers Pharma Advancements Through Strategic Partnerships and Innovation: A Glimpse into Vision 2030: Growth Trajectory and Opportunities for Indian Pharma
15/02/2023
Dr. Reddy’s included in Bloomberg Gender-Equality Index for the 6th year in a row
15/02/2023
S&P Global’s Sustainability Yearbook for the 3rd year
04/11/2022
Dr. Reddy’s API received the excellence in API – Technical Documentation award at Aché Laboratórios Parcerias para a Excelência (Partnerships – Excellence) event!
03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021
07/10/2021
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
21/01/2021
Best Supply Chain Team of the Year - Pharma- 2021
07/10/2021
The winner of the Best Indian Company in the US - Manufacturing Sector for the year 2021
21/01/2021
Best Supply Chain Team of the Year - Pharma- 2021
03/11/2021
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2021
11/11/2021
The winner of the Corporate social responsibility (CSR) Initiative of the year at Global generics & Biosimilars Awards
19/10/2020
Dr. Reddy's recognized at the CPhI Pharma Awards 2020 as the winner in the category of ‘Excellence in Pharma: Sustainability’
03/11/2020
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2020
05/11/2020
Dr. Reddy’s Laboratories wins “API Supplier of the Year” award at the Global Generics & Biosimilars Awards 2019
Aviso Legal
Nenhuma informação neste site, incluindo qualquer referência a qualquer produto ou serviço, constitui uma oferta de venda ou pode ser interpretada como representando uma oferta de venda. Produtos protegidos por patentes válidas não são oferecidos ou fornecidos para uso comercial. No entanto, em certos casos, a critério exclusivo do Dr. Reddy e sujeito a requisitos legais locais, as quantidades de pesquisa de tais produtos podem ser oferecidas para fins de submissões regulatórias sob a Seção 107A da Lei de Patentes da Índia (isenção Bolar), onde quer que tais isenções regulatórias existam. Os compradores devem fazer sua avaliação independente do produto ou serviço, incluindo o cenário de patentes em seus respectivos mercados e serão responsáveis por todas as responsabilidades relacionadas a patentes. O Dr. Reddy se isenta de todas as garantias, expressas ou implícitas, incluindo, entre outras, garantias de comercialização, adequação a uma finalidade específica e não violação.